Search Results

Cellecta, Inc. today announced the launch of the DriverMap™ Adaptive Immune Receptor (AIR) Human RNA Spike-In Premixed Controls, the first commercially available collection of synthetic mRNA constructs that can serve as universal controls for commercial or home-brewed AIR repertoire sequencing (AIR-Seq, TCR-seq and BCR-seq) assays based on multiplex RT-PCR or 5' RACE PCR techniques.

Cellecta, Inc. announced the release of new pooled, single-module, CRISPR genome-wide knockout libraries for chicken and pig.

Cellecta, Inc. today announced the launch of the DriverMap™ Adaptive Immune Receptor (AIR) Mouse RNA TCR and BCR kits.

Cellecta, Inc. today announced the launch of the DriverMap™ Adaptive Immune Receptor DNA (AIR-DNA) TCR and BCR kits which provide rapid, single-tube PCR-based assays to analyze the genomic diversity of receptors from T-cells or B-cells from a wide range of sample types, including whole blood, tissue biopsies, FFPE and more.

Cellecta, Inc. announced the launch of the DriverMap™ Adaptive Immune Receptor TCR and BCR kits, a family of multiplex-PCR, NGS-based assays that enable profiling of up to all seven T-cell receptor and B-cell receptor chains from the same sample, in a single tube, without need of specialized equipment.

◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.